Export HealthCatalyst Supports Norwegian Health Export Companies Entering Germany also in 2026!

Through the Norwegian government's export reform, HealthCatalyst provides Norwegian companies with advisory services, networks, and activities to strengthen their position in the German health market.

The board of HealthCatalyst AS consists of the leaders of the three clusters: Chair Arild Kristensen (NSCC), Ketil Widerberg (OCC), and Lena Nymo Helli (NHT).

A Collaborative Initiative for Health Export Growth

HealthCatalyst, consisting of Norway Health Tech, Oslo Cancer Cluster, Validé AS, and The Life Science Cluster, has been tasked with leading the government's health initiative in Germany under the export reform program "The Whole of Norway Exports". Germany has been identified as a key market for Norwegian health tech companies looking to increase exports. The project focuses especially on companies with existing export revenues aiming to expand their market share. This program started in 2025, and will now continue in 2026. For more information about the program see here!